Glucagon-like peptide-1 receptor agonists tied to higher thyroid cancer risk in first year of treatment
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...
Neurology Advisor2d
GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss
For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.
dermatologyadvisor2d
GLP-1 RAs Tied to Higher Thyroid Cancer Risk in First Year of Treatment
The absolute risk for thyroid cancer is low among patients receiving GLP-1 RA therapy, but risk is elevated in the first year of treatment.
Nature4y
G-Protein-Coupled Receptors, Pancreatic Islets, and Diabetes
such as glucagon-like peptide-1, free fatty acids, and catecholamines. With this knowledge, scientists are seeking to better understand the role of GPCRs in islet biology and hormone secretion ...
Medscape1mon
Early Intervention Central to Treating Muscle Mass Loss in Patients Losing Weight With GLP-1 Meds
With glucagon-like peptide 1 (GLP-1) agonists now close to inducing weight loss at levels only seen before through surgical intervention, obesity specialists say patients on these drugs are ...
Hosted on MSN1mon
Flavonoids in polyphenols: Activating gut hormones to improve health
triggering the release of glucagon-like peptide-1 (GLP-1), a hormone that plays a crucial role in regulating blood sugar levels. This study was made available online on November 5, 2024 ...